Demineralized Bone Matrix Market

Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.

Demineralized Bone Matrix Market contains market size and forecasts of Demineralized Bone Matrix (DBM) in global, including the following market information:

Global Demineralized Bone Matrix (DBM) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Demineralized Bone Matrix (DBM) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Demineralized Bone Matrix (DBM) companies in 2021 (%)

The global Demineralized Bone Matrix (DBM) market was valued at 563.9 million in 2021 and is projected to reach US$ 719.4 million by 2028, at a CAGR of 3.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Gel Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Demineralized Bone Matrix (DBM) include Medtronic, J &J (DePuy Synthes), Zimmer Biomet, Stryker, SeaSpine, Straumann, Xtant Medical, Wright Medical Group and Hans Biomed and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Demineralized Bone Matrix (DBM) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Demineralized Bone Matrix (DBM) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Demineralized Bone Matrix (DBM) Market Segment Percentages, by Type, 2021 (%)

• Gel
• Putty
• Putty with Chips
• Others

Global Demineralized Bone Matrix (DBM) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Demineralized Bone Matrix (DBM) Market Segment Percentages, by Application, 2021 (%)

• Dental Surgery
• Spine Surgery
• Trauma Surgery

Global Demineralized Bone Matrix (DBM) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Demineralized Bone Matrix (DBM) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Demineralized Bone Matrix (DBM) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Demineralized Bone Matrix (DBM) revenues share in global market, 2021 (%)
• Key companies Demineralized Bone Matrix (DBM) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Demineralized Bone Matrix (DBM) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medtronic
• J &J (DePuy Synthes)
• Zimmer Biomet
• Stryker
• SeaSpine
• Straumann
• Xtant Medical
• Wright Medical Group
• Hans Biomed
• Arthrex